[Combined therapy with mitoxantrone and cytosine arabinoside as a first-line treatment in ANLL: preliminary results].
Angós
J A
JA
Gutiérrez
M
M
Moreno
J A
JA
Aguado
M J
MJ
Romero
M S
MS
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
D003561:Cytarabine; D008942:Mitoxantrone
Terapéutica combinada con mitoxantrone y arabinósido de citosina como tratamiento de primera linea en LANL: resultados preliminares.